User profiles for Gregory E Crawford

Gregory Crawford

Duke University
Verified email at duke.edu
Cited by 68318

[HTML][HTML] High-resolution mapping and characterization of open chromatin across the genome

…, EH Margulies, Z Weng, TS Furey, GE Crawford - Cell, 2008 - cell.com
Mapping DNase I hypersensitive (HS) sites is an accurate method of identifying the location
of genetic regulatory elements, including promoters, enhancers, silencers, insulators, and …

[HTML][HTML] The accessible chromatin landscape of the human genome

…, PJ Sabo, R Kaul, TS Furey, J Dekker, GE Crawford… - Nature, 2012 - nature.com
DNase I hypersensitive sites (DHSs) are markers of regulatory DNA and have underpinned
the discovery of all classes of cis-regulatory elements including enhancers, promoters, …

Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome

…, W Wang, Z Weng, RD Green, GE Crawford… - Nature …, 2007 - nature.com
Eukaryotic gene transcription is accompanied by acetylation and methylation of nucleosomes
near promoters, but the locations and roles of histone modifications elsewhere in the …

Genome-wide mapping of DNase hypersensitive sites using massively parallel signature sequencing (MPSS)

GE Crawford, IE Holt, J Whittle, BD Webb, D Tai… - Genome …, 2006 - genome.cshlp.org
A major goal in genomics is to understand how genes are regulated in different tissues,
stages of development, diseases, and species. Mapping DNase I hypersensitive (HS) sites …

Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression

…, B Couvy-Duchesne, N Craddock, GE Crawford… - Nature …, 2018 - nature.com
Major depressive disorder (MDD) is a common illness accompanied by considerable
morbidity, mortality, costs, and heightened risk of suicide. We conducted a genome-wide …

Histone modifications at human enhancers reflect global cell-type-specific gene expression

…, R Stewart, JA Thomson, GE Crawford… - Nature, 2009 - nature.com
The human body is composed of diverse cell types with distinct functions. Although it is
known that lineage specification depends on cell-specific gene expression, which in turn is …

Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers

…, CM Vockley, PI Thakore, GE Crawford… - Nature …, 2015 - nature.com
Technologies that enable targeted manipulation of epigenetic marks could be used to
precisely control cell phenotype or interrogate the relationship between the epigenome and …

DNase-chip: a high-resolution method to identify DNase I hypersensitive sites using tiled microarrays

GE Crawford, S Davis, PC Scacheri, G Renaud… - Nature …, 2006 - nature.com
Mapping DNase I hypersensitive sites is an accurate method of identifying the location of gene
regulatory elements, including promoters, enhancers, silencers and locus control regions. …

RNA-guided gene activation by CRISPR-Cas9–based transcription factors

…, DG Ousterout, KW Leong, F Guilak, GE Crawford… - Nature …, 2013 - nature.com
Technologies for engineering synthetic transcription factors have enabled many advances
in medical and scientific research. In contrast to existing methods based on engineering of …

Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements

…, AM Kabadi, TE Reddy, GE Crawford… - Nature …, 2015 - nature.com
Epigenome editing with the CRISPR (clustered, regularly interspaced, short palindromic
repeats)-Cas9 platform is a promising technology for modulating gene expression to direct cell …